McLaren Cancer Institute-Northern Michigan — Petoskey, Michigan

McLaren Cancer Institute-Northern Michigan is a clinical research site located in Petoskey, Michigan, United States 49770.

Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

McLaren Cancer Institute-Northern Michigan has participated in 80 clinical trials with 52 currently active.

Therapeutic areas: Plasma Cell Myeloma, Colorectal Adenocarcinoma, Limited Stage Lung Small Cell Carcinoma.

Sponsors: ECOG-ACRIN Cancer Research Group, Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for McLaren Cancer Institute-Northern Michigan?

McLaren Cancer Institute-Northern Michigan has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has McLaren Cancer Institute-Northern Michigan conducted?

McLaren Cancer Institute-Northern Michigan has 80 clinical trials on record, with 52 currently active. Their work covers Plasma Cell Myeloma, Colorectal Adenocarcinoma, Limited Stage Lung Small Cell Carcinoma.

Is McLaren Cancer Institute-Northern Michigan accredited by Crixeo Health?

McLaren Cancer Institute-Northern Michigan has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about McLaren Cancer Institute-Northern Michigan?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.